Background:
Asthma is characterized by variable airflow limitation. FEF
25–75
has been proposed as a reliable marker for bronchial obstruction, especially when FEV
1
and FEV
1
/FVC are normal.
Objectives:
To investigate the role of FEF
25–75
in patients with asthma seen in clinical settings.
Materials and methods:
The cross-sectional study included 439 (181 females and 255 males; mean age 39 years) outpatients with asthma who consecutively visited an allergy clinic for a routine assessment. History, physical examination, asthma control, and spirometry were evaluated.
Results:
FEF
25–75
was impaired (< 65% of predicted) in 136 (31%) outpatients. Considering only subjects with normal FEV
1
and FEV
1
/FVC, FEF
25–75
was impaired in 71 (19.6%) subjects. In this subset, impaired FEF
25–75
was associated with low FEV
1
and FEV
1
/FVC values (OR 0.91 and 0.85, respectively), and presence of asthma symptoms (OR 2.19).
Conclusion:
FEF
25–75
deserves adequate and careful consideration in patients with asthma and normal FEV
1
and FEV
1
/FVC, as the presence of impaired FEF
25–75
in this subset suggests a more specific approach.